![]() |
市场调查报告书
商品编码
1861118
全球经肠营养设备市场:市场规模、份额和趋势分析(2026-2032 年)Enteral Feeding Device Market Size, Share, and Trends Analysis | Global | 2026-2032 | Includes: Feeding Pumps, Enteral Feeding sets, and Enteral Feeding Tubes |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球经肠营养设备市场预计到2025年将超过34亿美元。预计该市场将以3.2%的复合年增长率成长,到2032年达到约43亿美元。
本报告涵盖肠道餵食帮浦、经肠营养装置和经肠营养管,这些产品共同构成了全球完整的经肠营养设备市场。报告量化了销售、平均售价、市场价值、成长率和企业市场占有率,并分析了市场趋势和驱动因素、近期併购活动以及技术发展。报告提供截至2022年的历史数据,并预测至2032年。
它反映了世界各地的医疗机构如何评估医院、疗养院和居家照护环境中的经肠营养技术,重点关注患者的舒适度、成本效益和程序安全性。
市场概览
经肠营养装置对于无法透过口服摄取满足营养需求的患者至关重要。这些装置包括帮浦、餵食管和输液器,它们以可控的方式将液态营养物质直接输送到消化道。
过去十年,经肠营养已成为长期患者照护的重要组成部分,尤其是在慢性病、神经系统疾病、癌症和老龄化相关疾病患者群体中。营养不良和胃肠道疾病盛行率的不断上升,以及医疗保健服务可近性和报销政策的改善,持续推动市场成长。
儿童经肠营养是推动整体市场扩张的重要因素。儿童病例的报销率约为成人的三倍,这鼓励医生更频繁地进行此类手术。家长意识的提高以及与经肠营养相关的社会偏见的减少,使得家长更容易接受这种治疗方法。因此,儿童病例正成为製造商实现成长和差异化的关键领域。
此外,对替换装置(尤其是低轮廓球囊和非球囊导管)的需求持续推动市场成长。这些替换手术通常可以在家中或护理机构进行,而无需住院,这既方便了患者,也为医疗机构节省了成本。
儘管价格仍面临压力,技术创新也在放缓,但整体手术量和患者接受率都在增加,这些趋势支撑着已开发和新兴医疗保健市场在全球范围内的稳定收入成长。
市场驱动因素
儿科经肠营养程序
儿童经肠营养的兴起是推动市场发展最重要的因素之一。更高的报销率和更佳的设备安全性促使医生向儿童推荐经肠营养。家长也越来越意识到早期营养介入的益处,并且比以往更容易接受管饲。
社会偏见的减少以及经肠营养疗效的普及,促使人们能够对婴幼儿进行早期疗育,以对抗饮食障碍。预计这些趋势将在预测期内持续,为儿科营养生产商带来巨大的长期成长机会。
替换装置
在全球市场,替换式餵食管正推动持续的收入成长。虽然初次置入通常需要在医疗机构进行,但更换过程通常可以在门诊病人或居家照护环境中完成。
这种便利性降低了操作难度,使患者能够更长时间地使用经肠营养系统。由于维护更简单、舒适度更高,带气囊和不带气囊的低位肠内营养管都越来越受欢迎。因此,替换产品对销售量和整体市场稳定性做出了显着贡献。
细管
低位肠内营养管的隐藏设计和较高的患者舒适度提高了经肠营养的接受度。这些导管较不易被察觉,并提供更大的活动自由度,进而改善病患的生活品质。
特别是低位气球管,正日益取代标准的经皮视镜胃造瘻术(PEG)管。重要的是,球囊管的日益普及不仅取代了现有产品的销量,而且还透过吸引以前拒绝长期营养干预的新患者,扩大了整体市场。
家庭护理和替代护理的增长
向家庭经肠营养的转变是另一个主要的市场驱动因素。随着医疗系统寻求降低住院成本,越来越多的患者出院时都配备了经肠营养系统。这些设备操作简单、便携且安全,使得看护者和患者能够在极少监督的情况下在家中管理营养。
这种转变也使製造商受益,因为定期购买餵食器和替换管材可以带来持续的收入。小型电池驱动肠内营养泵的持续发展进一步推动了居家照护领域的扩张。
市场限制
缺乏新技术
近年来,经肠营养设备市场技术进步有限。核心产品设计基本上保持不变,导致平均售价持平甚至下降。儘管在易用性和材料设计方面有所改进,但鲜有重大突破足以支撑其高价。
此外,更换手术过程令人不适,降低了患者接受新型号产品的意愿。缺乏引人注目的技术创新,加上持续的价格压力,预计将在2032年之前抑制价格成长。
併发症风险
儘管经肠营养是一种成熟的治疗方法,但与导管相关的併发症仍然是临床上关注的问题。常见问题包括导管移位、渗漏、感染和代谢失衡。这些风险使得医生和患者在考虑长期经肠营养都犹豫不决。
持续优先考虑安全性而非疗效的做法可能会减缓新产品或先进产品的推广应用。如果出现疗效相当但併发症风险较低的替代营养输送技术,经肠营养市场在某些临床领域可能会面临竞争压力。
兑换限制
虽然儿科医疗的报销率较为优惠,但成人医疗的报销政策因市场而异。在保险覆盖范围限制严格的地区,医院可能不愿意投资昂贵的输液帮浦及其配件。这些限制,加上开发中国家缺乏统一的报销框架,限制了平均售价的成长,并延缓了设备的更新换代週期。
目标市场和数据范围
定量范围
市场规模、市占率、市场预测、成长率、销售量、平均售价
定性范围
成长趋势、限制因素、竞争分析、竞争对手SWOT分析、併购、公司概况和产品系列、FDA召回事件、颠覆性技术、疾病概述,这些因素共同影响经肠营养设备的需求。
时期
基准年为2025年,预测期间为2026-2032年,历史资料为2022-2024年。
数据来源
主要研究内容包括:对行业高管、临床医生和采购专业人员的访谈、政府资料库、进出口记录以及iData Research的内部资料储存库。
方法注记
销售模型是透过将单位数量乘以平均售价 (ASP) 来建立的,并根据假设的护理机构利用率和更换率检验。
目标市场及区隔
肠道餵食帮浦
经肠营养套装
经肠营养管
竞争分析
Avanos Medical在2025年引领了全球经肠营养管市场。该公司前身为Halyard Health,在2018年将其外科和感染预防业务出售给Owens & Minor后更名为Avanos Medical。 2016年收购CORPAK MedSystems进一步巩固了其在经肠营养领域的地位。 Avanos的产品线以其可靠性、安全性和符合ENFit®连接器标准而广受认可,确保了其在医院和家庭护理机构之间的兼容性。
费森尤斯卡比是全球经肠营养设备市场第二大竞争者。凭藉其德国血统和在当地享有的产品品质声誉,该公司在德国、奥地利和瑞士市场拥有尤为强大的领先地位。费森尤斯卡比销售的Amika®肠道餵食帮浦和符合ENFit®标准的Freka®营养管广泛应用于医院和养老院。
2025年,康德乐在全球市场排名第三。该公司的优势在于其全面的Kangaroo™产品线,包括输液帮浦、输液管和输液器套装。 Kangaroo™系统广泛应用于医院、居家医疗和长期照护机构,以其简单性、安全性和与ENFit®相容的设计而闻名。凭藉其广泛的分销网络和对产品可靠性的重视,康德乐在多个地区保持主导地位。
整体而言,竞争格局持续温和整合,这三家公司总合占据了相当大的市场份额。亚太和拉丁美洲的区域製造商主要在价格上竞争,提供高性价比的产品以满足新兴市场日益增长的需求。
科技与临床趋势
ENFit® 标准化持续推动全球应用,提高病患安全并降低误连接的风险。
可携式和电池驱动的帮浦在家庭和门诊使用中越来越受欢迎,提高了患者的活动能力。
由于提高了患者的舒适度和美观性,低轮廓餵食管仍然是成长最快的产品细分市场。
引入增强材料和防堵塞涂层,以提高管道寿命并减少维护。
追踪餵食参数和设备性能的数位监控系统正在逐渐出现,主要出现在先进的医疗保健市场。
与居家医疗的融合不断扩大,简化的营养包被引入医院外,供看护者使用。
地区
本期内容涵盖北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。
调查方法附录与简称
图表清单
图表列表
调查方法
全球关税的影响
经肠营养设备市场
The global enteral feeding device market was valued at over $3.4 billion in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.2 percent to reach nearly $4.3 billion by 2032.
This report covers enteral feeding pumps, enteral feeding sets, and enteral feeding tubes, which together make up the complete global market for enteral feeding devices. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and it analyzes market drivers and limiters, recent mergers and acquisitions, and technology trends. The report provides historical data to 2022 and forecasts through 2032.
The scope reflects how healthcare systems worldwide evaluate enteral feeding technologies across hospitals, nursing homes, and home care environments, focusing on patient comfort, cost efficiency, and procedural safety.
Market Overview
Enteral feeding devices are essential for providing nutritional support to patients who are unable to meet their dietary needs through oral intake. These devices include pumps, feeding tubes, and sets used for the controlled delivery of liquid nutrition directly into the gastrointestinal tract.
Over the last decade, enteral feeding has become a critical component of long-term patient care, particularly among populations affected by chronic illnesses, neurological disorders, cancer, and age-related conditions. Market growth continues to be supported by the expanding prevalence of malnutrition and gastrointestinal disease, coupled with improvements in healthcare access and reimbursement policies.
Pediatric enteral feeding procedures are a notable contributor to overall market expansion. Reimbursement rates for pediatric cases are approximately three times higher than for adults, encouraging physicians to perform these procedures more frequently. Greater parental awareness and the reduction of social stigma associated with enteral feeding have made parents more open to this therapy for children. As a result, pediatric cases are becoming a key area of growth and differentiation for manufacturers.
Additionally, replacement device demand-particularly for low-profile balloon and non-balloon tubes-continues to strengthen market performance. These replacement procedures can often be carried out in home or nursing care settings rather than hospitals, providing convenience for patients and reducing costs for providers.
Although pricing remains under pressure and technological innovation has slowed, overall procedure volumes and patient adoption are rising. This trend supports steady global revenue growth across both developed and emerging healthcare markets.
Market Drivers
Pediatric Enteral Feeding Procedures
The rise in pediatric enteral feeding procedures is one of the most significant market drivers. Physicians are more likely to recommend enteral feeding for children given the higher reimbursement rates and improved device safety. Parents are increasingly aware of the benefits of early nutritional intervention and are more accepting of feeding tubes than in the past.
The reduction in social stigma, combined with widespread education on the effectiveness of enteral feeding, has led to earlier intervention for infants and young children who struggle with feeding disorders. These trends are expected to continue over the forecast period, representing a major long-term growth opportunity for manufacturers targeting pediatric applications.
Replacement Devices
Replacement feeding tubes are driving recurring revenue streams across the global market. While initial placements typically require a clinical setting, replacements can often be managed in outpatient or home care environments.
This convenience reduces procedural barriers and encourages patients to continue using enteral feeding systems for extended periods. Both balloon and non-balloon low-profile tubes are gaining adoption due to their ease of maintenance and improved comfort. As a result, replacement products are contributing significantly to unit sales and overall market stability.
Low-Profile Tubes
The discreet design and greater patient comfort offered by low-profile enteral tubes have increased acceptance of enteral feeding. These tubes are less visible and allow greater freedom of movement, improving patient quality of life.
Low-profile balloon tubes, in particular, are increasingly replacing standard percutaneous endoscopic gastrostomy (PEG) tubes. Importantly, their growing popularity is not merely substituting existing sales but expanding the total market by attracting new patients who previously declined long-term feeding interventions.
Home and Alternate Care Growth
The shift toward home-based enteral nutrition is another key market driver. As healthcare systems aim to reduce inpatient costs, more patients are being discharged with enteral feeding systems. Improved device usability, portability, and safety features enable caregivers and patients to manage feeding at home with minimal supervision.
This transition also benefits manufacturers, as recurring purchases of feeding sets and replacement tubes generate ongoing revenue. Continued development of compact, battery-operated enteral pumps further supports the expansion of the home care segment.
Market Limiters
Lack of New Technology
The enteral feeding device market has seen limited technological advancement in recent years. Core product designs have remained largely unchanged, contributing to flat or declining ASPs. While incremental improvements in usability and material design exist, there have been few major breakthroughs that would justify premium pricing.
Patients also demonstrate limited interest in adopting new models since replacement procedures can be uncomfortable. The lack of compelling innovation, combined with ongoing pricing pressure, is expected to maintain subdued price growth through 2032.
Risk of Complications
Although enteral feeding is a well-established therapy, device-related complications remain a clinical concern. Common issues include tube dislodgment, leakage, infection, and metabolic imbalances. These risks can deter both physicians and patients from prolonged enteral feeding.
As safety continues to be prioritized over efficiency, the adoption of new or advanced products can slow. If alternative nutritional delivery technologies emerge that offer equal efficacy with lower complication risk, the enteral feeding market could face competitive pressure in certain clinical segments.
Reimbursement Constraints
While reimbursement rates for pediatric procedures are favorable, adult reimbursement policies remain uneven across markets. In regions with strict coverage limits, hospitals may be reluctant to invest in premium pumps or accessories. These constraints, combined with the absence of uniform reimbursement frameworks in developing economies, limit ASP growth and delay device replacement cycles.
Market Coverage and Data Scope
Quantitative Coverage
Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative Coverage
Growth trends, limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls, disruptive technologies, and disease overviews that shape demand for enteral feeding devices.
Time Frame
Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
Data Sources
Primary interviews with industry executives, clinicians, and procurement specialists; government databases; import and export records; and the iData Research internal data repository.
Method Note
Revenue is modeled from units multiplied by ASP, validated with utilization rates and replacement assumptions across care settings.
Markets Covered and Segmentation
Enteral Feeding Pump
Enteral Feeding Set
Enteral Feeding Tube
Competitive Analysis
Avanos Medical led the global enteral feeding tube market in 2025. Formerly known as Halyard Health, the company rebranded as Avanos Medical in 2018 following the divestment of its surgical and infection prevention business to Owens & Minor. Its acquisition of CORPAK MedSystems in 2016 strengthened its position in the enteral feeding segment. Avanos' product lines are widely recognized for their reliability, safety, and compliance with ENFit(R) connector standards, ensuring compatibility across hospitals and home care providers.
Fresenius Kabi ranked as the second-largest competitor in the global market for enteral feeding devices. The company's leadership is particularly strong in Germany, Austria, and Switzerland, supported by its German origins and regional reputation for product quality. Fresenius Kabi markets the Amika(R) enteral feeding pump and ENFit(R)-compliant Freka(R) feeding tubes, which are used extensively in both hospital and long-term care environments.
Cardinal Health ranked third in the global market in 2025. The company's strength lies in its comprehensive Kangaroo(TM) product line, which includes feeding pumps, tubes, and sets. The Kangaroo(TM) systems are widely used across hospitals, home healthcare, and long-term care facilities, valued for their simplicity, safety, and ENFit(R)-compatible design. Cardinal Health's broad distribution networks and focus on reliability have enabled it to maintain a leading position in multiple regions.
Overall, the competitive landscape remains moderately consolidated, with these three companies collectively accounting for a substantial share of total market revenues. Regional manufacturers in Asia-Pacific and Latin America compete primarily on price, offering cost-effective products to meet growing demand in emerging markets.
Technology and Practice Trends
ENFit(R) standardization continues to drive global adoption, improving patient safety and reducing the risk of misconnections.
Portable and battery-powered pumps are gaining popularity for home and ambulatory use, enhancing patient mobility.
Low-profile feeding tubes remain the fastest-growing product subsegment due to improved patient comfort and aesthetic appeal.
Reinforced materials and anti-clog coatings are being introduced to improve tube longevity and reduce maintenance frequency.
Digital monitoring systems that track feeding parameters and device performance are emerging gradually, primarily in advanced healthcare markets.
Home healthcare integration continues to expand, with simplified feeding sets designed for caregiver use outside hospital settings.
Geography
This edition covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Methodology Appendix and Acronym Glossary
Where are the largest and fastest-growing opportunities within the global enteral feeding device market
How are pediatric procedures and replacement trends driving sustained unit growth
What are the key limitations to ASP expansion, and how do manufacturers manage pricing pressure
Which product innovations, such as low-profile tubes and portable pumps, are shaping the market outlook
How are leading companies-Avanos Medical, Fresenius Kabi, and Cardinal Health-differentiating their portfolios and maintaining share
What procedural and reimbursement factors will shape growth through 2032
The Global Enteral Feeding Device Market Report from iData Research answers these questions with detailed procedure-based models, company share data, and price trend analysis. Use it to evaluate market potential, plan commercial strategy, and align R&D initiatives with emerging clinical needs.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Enteral Feeding Device Market